CA2550610A1 - Use of gaboxadol for treating insomnia - Google Patents

Use of gaboxadol for treating insomnia Download PDF

Info

Publication number
CA2550610A1
CA2550610A1 CA002550610A CA2550610A CA2550610A1 CA 2550610 A1 CA2550610 A1 CA 2550610A1 CA 002550610 A CA002550610 A CA 002550610A CA 2550610 A CA2550610 A CA 2550610A CA 2550610 A1 CA2550610 A1 CA 2550610A1
Authority
CA
Canada
Prior art keywords
gaboxadol
insomnia
treatment
oral dose
dose form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002550610A
Other languages
English (en)
French (fr)
Inventor
Bjarke Ebert
Jonas Lundahl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H Lundbeck AS
Original Assignee
H. Lundbeck A/S
Bjarke Ebert
Jonas Lundahl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34684447&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2550610(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H. Lundbeck A/S, Bjarke Ebert, Jonas Lundahl filed Critical H. Lundbeck A/S
Publication of CA2550610A1 publication Critical patent/CA2550610A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/423Oxazoles condensed with carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
CA002550610A 2003-12-18 2004-12-14 Use of gaboxadol for treating insomnia Abandoned CA2550610A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKDKPA200301877 2003-12-18
DKPA200301877 2003-12-18
PCT/DK2004/000861 WO2005058313A1 (en) 2003-12-18 2004-12-14 Use of gaboxadol for treating insomnia

Publications (1)

Publication Number Publication Date
CA2550610A1 true CA2550610A1 (en) 2005-06-30

Family

ID=34684447

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002550610A Abandoned CA2550610A1 (en) 2003-12-18 2004-12-14 Use of gaboxadol for treating insomnia

Country Status (17)

Country Link
EP (1) EP1720547A1 (ru)
JP (1) JP2007515415A (ru)
KR (1) KR20060103335A (ru)
CN (1) CN1893942A (ru)
AR (1) AR047154A1 (ru)
AU (1) AU2004298313A1 (ru)
BR (1) BRPI0415893A (ru)
CA (1) CA2550610A1 (ru)
EA (1) EA200600989A1 (ru)
IL (1) IL176239A0 (ru)
IS (1) IS8390A (ru)
MX (1) MXPA06006685A (ru)
NO (1) NO20063320L (ru)
SG (1) SG133601A1 (ru)
TW (1) TW200528098A (ru)
WO (1) WO2005058313A1 (ru)
ZA (1) ZA200602762B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0402118D0 (en) 2004-01-30 2004-03-03 Merck Sharp & Dohme Polymorphic forms of a GABAA agonist
EP1906953A4 (en) * 2005-04-29 2009-05-20 Lundbeck & Co As H FORMS OF ACID SALTS AND BASIC SALTS OF GABOXADOL
WO2019055369A1 (en) * 2017-09-12 2019-03-21 Ovid Therapeutics Inc. USE OF GABOXADOL IN THE TREATMENT OF NARCOLEPSIA
EP3833351A4 (en) 2018-09-20 2021-10-13 Ovid Therapeutics Inc. USE OF GABOXADOL TO TREAT TOURETTE SYNDROME, TICKS, AND STUTTERS
AU2019405489A1 (en) 2018-12-17 2021-06-10 Ovid Therapeutics Inc. Use of gaboxadol for the treatment of non-24 hour sleep-wake disorder
WO2021127308A1 (en) 2019-12-18 2021-06-24 Ovid Therapeutics Inc. GABOXADOL FOR THERAPEUTIC TREATMENT OF 1p36 DELETION SYNDROME

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19525598C2 (de) * 1995-07-13 1997-09-25 Max Planck Gesellschaft Schlafmittel
JP2004530695A (ja) * 2001-05-21 2004-10-07 ハー・ルンドベック・アクチエゼルスカベット ガボキサドールの顆粒状調合物

Also Published As

Publication number Publication date
AR047154A1 (es) 2006-01-11
TW200528098A (en) 2005-09-01
BRPI0415893A (pt) 2007-01-09
ZA200602762B (en) 2007-06-27
MXPA06006685A (es) 2006-08-23
SG133601A1 (en) 2007-07-30
CN1893942A (zh) 2007-01-10
WO2005058313A1 (en) 2005-06-30
AU2004298313A1 (en) 2005-06-30
KR20060103335A (ko) 2006-09-28
JP2007515415A (ja) 2007-06-14
EP1720547A1 (en) 2006-11-15
IL176239A0 (en) 2006-10-05
IS8390A (is) 2006-03-30
NO20063320L (no) 2006-07-18
EA200600989A1 (ru) 2006-10-27

Similar Documents

Publication Publication Date Title
AU723954B2 (en) Non-allosteric gabaA agonists for treating sleep disorders
US9700548B2 (en) Antihistamines combined with dietary supplements for improved health
US20080269278A1 (en) Treatment of Impaired Respiratory Function with Gaboxadol
HU217136B (hu) Riluzol alkalmazása Parkinson-kór és Parkinson-szindrómák kezelésére szolgáló gyógyszerkészítmények előállítására
EP1154795B1 (en) Means for treating and diagnosing restless legs syndrome
JPH11501282A (ja) コリン受容体作用薬及び拮抗薬としてのエピバチジン及びその誘導体
US20050203124A1 (en) Compounds for the sustained reduction of body weight
EA028060B1 (ru) Комбинированная терапия бокового амиотрофического склероза
US20050137222A1 (en) Treatment of insomnia in human patients
KR20090120423A (ko) 조루증 치료를 위한 경구용 의약 조성물
CA2550610A1 (en) Use of gaboxadol for treating insomnia
CA2572302A1 (en) Treatment of neuropathic pain, fibromyalgia or rheumatoid arthritis
JP2007515415A6 (ja) 不眠症の治療にガボクサドールを使用する方法
US5414005A (en) Methods and articles of manufacture for the treatment of nicotine withdrawal and as an aid in smoking cessation
JPH0196131A (ja) 睡眠障害および鬱病を治療するためのある種の化合物の使用
EP1611901B1 (en) Preventive or remedy for teeth grinding
JP3064360B2 (ja) 痴呆治療剤
AU736514B2 (en) Non-allosteric gabaa agonists for treating sleep disorders
US20190008188A1 (en) Antihistamines Combined with Dietary Supplements for Improved Health
JP2022529290A (ja) 呼吸性不整脈を処置するための方法および組成物

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued